Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

48 results for Pharmaceuticals
CLEAR ALL
Actylis
Buffering agent and pH modifier developed exclusively for use in injectable formulations.Benefits:
  • DMF Filed - CDE # F20200000141
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
Actylis
Solvent and co-solvent designed for injectable formulations. This excipient is used as a buffering agent and pH modifier. Benefits:
  • Highly pure, gives sweet taste
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with CDMF, USP, Ph Eur specification
Actylis
Solvent designed for oral solid dosage forms. It is used as a surfactant and permeation enhancer for transdermal patches. It can also be used as a humectant, stabilizer and emulsifying agent for solid and semi-solid dosage formulations. Benefits:
  • Highly pure
  • Complies with USP-NF and CDMF
Actylis
Excipient designed for transdermal drug delivery system. It is applicable in transdermal patches.Benefits:
  • Purity: 99.80 % (Gas Chromatography)
  • Helps to improve drug efficacy
  • Meets with CDMF specifications
Actylis
Excipient designed for pharmaceutical applications. It is used to adjust pH in solid and semi-solid dosage formulations.Benefits:
  • Complies with USP, Ph Eur and CP specifications
Actylis
Excipient developed for pharmaceutical applications.  It functions as a preservative in solid and semi-solid dosage forms. Benefits:
  • Meets with CDMF specifications
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Excipient having possible use in pharmaceutical applications.
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Excipient for use in pharmaceutical applications. It acts as a preservative. 
Actylis
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient developed for pharmaceutical applications. It acts as an antioxidant.
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189